Only 8 US States Mandate Perinatal Mental Health Screening — And Most Do It Poorly
- Only 8 US states have legislated mandates for perinatal mental health screening; 10 states total have passed any screening-related legislation since New Jersey's first law in 2000
- The Policy Center for Maternal Mental Health identified 7 key criteria for a robust screening law — no state meets all 7, and only 3 states meet a minimum of 3 criteria
- Most recent mandates (Louisiana 2022, Arkansas 2023) are narrower than earlier ones — limiting screening to postpartum depression only, or to inpatient/pediatric settings, missing pregnancy and the broader spectrum of perinatal mood disorders
- 50-70% of maternal mental health disorders go undiagnosed; 75% of those diagnosed go untreated — screening mandates without treatment infrastructure and reimbursement address only the first failure point
The number itself should end the conversation about whether policy is keeping pace with evidence. Eight states. In a country of fifty. Twenty-five years after the first mandate, the United States still has no federal requirement for perinatal mental health screening. And the states that have acted are mostly doing it wrong.
The Policy Center for Maternal Mental Health published a comprehensive analysis of every state screening and reimbursement law passed since New Jersey's landmark 2000 legislation. The findings are sobering for anyone who assumed the policy landscape was improving.
The Legislative Landscape
New Jersey acted first in 2000, mandating postpartum depression screening. West Virginia followed nearly a decade later in 2009. Then California, Florida, Oklahoma, and Illinois in rapid succession. Louisiana in 2022. Arkansas in 2023. Nevada and Washington passed reimbursement-related legislation in 2023 but stopped short of screening mandates.
The trajectory looks like progress. It is not.
The Policy Center evaluated each law against 7 criteria for a robust screening mandate: (1) requires obstetric providers to screen, (2) includes pregnancy in the screening timeframe, (3) links screening to state support services, (4) requires insurers to monitor screening rates, (5) mandates use of validated tools, (6) addresses reimbursement, (7) establishes reporting mechanisms. No state meets all seven. Only three states meet three or more.
The most recent laws are weaker than earlier ones. Louisiana's 2022 mandate limits screening to pediatricians — not obstetricians, the providers who see perinatal patients. Arkansas's 2023 law applies only in the inpatient setting at birth. Both focus exclusively on postpartum depression, ignoring anxiety, OCD, PTSD, and psychosis — conditions that are clinically common and diagnostically distinct in the perinatal population.
The California Problem
California's experience illustrates the central failure mode. Since 2019, providers are required to screen during prenatal care and postpartum. The mandate exists. Compliance is improving. And yet the infrastructure to respond to positive screens remains inadequate.
Mandated screening in California identified more women. It did not treat more women. The screening-to-treatment pipeline leaks at every junction: specialist availability, insurance coverage, waitlists, childcare during appointments, transportation, stigma. California requires insurers to develop quality management programs addressing maternal mental health. Whether those programs translate into accessible treatment slots is a different question.
This is the fundamental tension: screening mandates are politically achievable. Treatment infrastructure mandates are not. The result is a system that identifies need without meeting it — a false safety net that checks a box while women fall through.
PSI and Federal Advocacy
Postpartum Support International has been the most consistent advocacy voice pushing for broader adoption. PSI recommends universal screening using the EPDS, endorsed by ACOG (2015), AAP (2010), and the USPSTF (2016). Their 2026 guidelines extend screening recommendations to partners, with an adjusted EPDS cutoff of 5/6 for fathers — recognizing that 1 in 10 fathers experience postpartum depression.
PSI's Mind the Gap initiative pushes toward a national strategic roadmap for perinatal mental health. Federal legislation mandating screening has been introduced repeatedly but has not passed. The political reality: mandating screening requires funding treatment, and funding treatment at national scale requires a commitment that no administration has made.
What Practitioners Need to Know
Whether or not your state mandates screening, ACOG and USPSTF guidelines recommend it. The clinical standard exists regardless of legislation. But practitioners operating in mandate states should understand what their specific law requires: which provider types, which timeframe (pregnancy, postpartum, or both), which conditions, and what documentation is expected.
More importantly, practitioners everywhere should be honest about what happens after a positive screen in their practice. If the answer is "we refer" — to whom? With what wait time? With what follow-up to confirm the patient connected? Screening without a referral pathway is an ethical problem, not just a systems problem.
Build your own pathway. Maintain an updated list of perinatal mental health specialists accepting new patients. Know your local PSI coordinator. Identify warm handoff protocols that work in your setting. The mandate may or may not arrive in your state. The clinical responsibility is already there.
Eight states mandate perinatal screening. No state meets all seven criteria for doing it well. The gap between legislation and infrastructure is where patients disappear.
The Policy Center analysis covers legislation through January 2024 and may not reflect laws passed or amended since. The report focuses on legislative mandates and does not capture state Medicaid EPSDT protocols, Medicaid agency contracts, or budget actions that may address screening. California's experience is cited from secondary analysis — the original Health Affairs Scholar paper examining mandated screening implementation was not accessible for detailed review. The 50-70% undiagnosed figure and 75% untreated figure are from prior research syntheses and may vary by methodology and population. PSI screening recommendations for fathers use an adjusted EPDS cutoff that is not yet universally validated across diverse populations.